Status:

RECRUITING

Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Myeloproliferative Neoplasm

Eligibility:

All Genders

18+ years

Brief Summary

Myeloproliferative Neoplasms (MPN) are associated with an increased risk of thrombosis. Platelets, red blood cells (RBC), leukocytes and endothelial cells are involved in these complications. An assoc...

Detailed Description

Myeloproliferative Neoplasms (MPN) are hematological malignancies associated with an increased risk of thrombosis. Although different cell types have been involved in these complications (platelets, r...

Eligibility Criteria

Inclusion Criteria:

  • Adult patient (age ≥ 18 years)
  • Inclusion at diagnosis or during the year following the diagnosis of PV or ET (2016 WHO criteria except bone marrow biopsy that is optional), before introduction of a cytoreductive treatment
  • Patient carrying a JAK2V617F mutation
  • Subject registered with a social security scheme
  • Written informed consent obtained
  • Acceptance of inclusion in the FIMBANK registry (specific consent form needed)

Exclusion Criteria:

  • ET or PV Patient not carrying a JAK2V617F mutation
  • Patient with cytoreductive treatment (hydroxyurea, anagrelide, interferon, ruxolitinib or other chemotherapy) at the time of blood sampling
  • Person under judicial safeguards, trustee or curatorship
  • Person unable to give her consent
  • Non-cooperative person
  • Exclusion period after another clinical study or participation to another clinical study in the 30 days before inclusion

Key Trial Info

Start Date :

June 19 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05839717

Start Date

June 19 2023

End Date

December 1 2025

Last Update

December 17 2024

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

CHU d'Angers, Service Maladies du Sang

Angers, France, 49933

2

CH de Bayonne, Service Hématologie Clinique

Bayonne, France, 64100

3

CHU de Bordeaux, Service Médecine Interne et Maladies Infectieuses

Bordeaux, France, 33000

4

Institut Bergonié, Service Hématologie Clinique

Bordeaux, France, 33000